BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24123114)

  • 1. Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T cells in immune-primed chimpanzees.
    Zubkova I; Duan H; Wells F; Mostowski H; Chang E; Pirollo K; Krawczynski K; Lanford R; Major M
    Hepatology; 2014 Mar; 59(3):803-13. PubMed ID: 24123114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.
    Nascimbeni M; Mizukoshi E; Bosmann M; Major ME; Mihalik K; Rice CM; Feinstone SM; Rehermann B
    J Virol; 2003 Apr; 77(8):4781-93. PubMed ID: 12663785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.
    Park SH; Shin EC; Capone S; Caggiari L; De Re V; Nicosia A; Folgori A; Rehermann B
    Gastroenterology; 2012 Oct; 143(4):1048-60.e4. PubMed ID: 22705008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.
    Radziewicz H; Ibegbu CC; Hon H; Bédard N; Bruneau J; Workowski KA; Knechtle SJ; Kirk AD; Larsen CP; Shoukry NH; Grakoui A
    J Immunol; 2010 Mar; 184(5):2410-22. PubMed ID: 20100932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.
    Hua S; Lécuroux C; Sáez-Cirión A; Pancino G; Girault I; Versmisse P; Boufassa F; Taulera O; Sinet M; Lambotte O; Venet A
    PLoS One; 2014; 9(7):e101920. PubMed ID: 25000587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.
    Bassett SE; Guerra B; Brasky K; Miskovsky E; Houghton M; Klimpel GR; Lanford RE
    Hepatology; 2001 Jun; 33(6):1479-87. PubMed ID: 11391537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.
    Shoukry NH; Grakoui A; Houghton M; Chien DY; Ghrayeb J; Reimann KA; Walker CM
    J Exp Med; 2003 Jun; 197(12):1645-55. PubMed ID: 12810686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of regeneration and tolerance factor correlates directly with human immunodeficiency virus infection and inversely with hepatitis C virus infection.
    Sung CC; Boomer JS; Givens TS; DuChateau BK; Lepe MR; Feller A; Westerman MP; Gilman-Sachs A; Chedid A; Beaman KD
    Clin Diagn Lab Immunol; 2000 Mar; 7(2):200-5. PubMed ID: 10702493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.
    Callendret B; Eccleston HB; Satterfield W; Capone S; Folgori A; Cortese R; Nicosia A; Walker CM
    Hepatology; 2016 May; 63(5):1442-54. PubMed ID: 26513111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD38
    Khandelwal P; Chaturvedi V; Owsley E; Lane A; Heyenbruch D; Lutzko CM; Leemhuis T; Grimley MS; Nelson AS; Davies SM; Jordan MB; Marsh RA
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):1-6. PubMed ID: 31442594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.
    Dahari H; Feinstone SM; Major ME
    Gastroenterology; 2010 Sep; 139(3):965-74. PubMed ID: 20621699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees.
    Elmowalid GA; Qiao M; Jeong SH; Borg BB; Baumert TF; Sapp RK; Hu Z; Murthy K; Liang TJ
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8427-32. PubMed ID: 17485666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
    Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
    Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group.
    Giorgi JV; Ho HN; Hirji K; Chou CC; Hultin LE; O'Rourke S; Park L; Margolick JB; Ferbas J; Phair JP
    J Infect Dis; 1994 Oct; 170(4):775-81. PubMed ID: 7930717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
    Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.
    Barth H; Rybczynska J; Patient R; Choi Y; Sapp RK; Baumert TF; Krawczynski K; Liang TJ
    Hepatology; 2011 Oct; 54(4):1135-48. PubMed ID: 21674561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
    Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
    J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.